Enveric Biosciences ENVB
NASDAQ ENVB
$1.51 +0.07 (+4.86%)
At close: Oct 21, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Preferred Stock Liabilities (2022)

Updated

Enveric Biosciences (ENVB) recorded Preferred Stock Liabilities of $527.00 in Q2 2022.

Analysis

Enveric Biosciences (ENVB) Preferred Stock Liabilities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Enveric Biosciences 6.02 Mn -15.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 527.00
API Access

Enveric Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ENVB&period=max&api_key=YOUR_API_KEY